PCNI8 A COST COMPARISON OF GEMZAR PLUS CISPLATIN WITH OTHER NOVEL AGENTS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY
Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)65752-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65752-X/fulltext
Section Title :
Section Order :
117
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65752-X&doi=10.1016/S1098-3015(10)65752-X